Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Mdm2 overexpression and p14ARF inactivation are two mutually exclusive events in primary human lung tumors

Oncogene volume 21, pages 2750–2761 (2002)Cite this article

Abstract

Pathways involving p53 and pRb tumor suppressor genes are frequently deregulated during lung carcinogenesis. Through its location at the interface of these pathways, Mdm2 can modulate the function of both p53 and pRb genes. We have examined here the pattern of expression of Mdm2 in a series of 192 human lung carcinomas of all histological types using both immunohistochemical and Western blot analyses and four distinct antibodies mapping different epitopes onto the Mdm2 protein. Using Immunohistochemistry (IHC), Mdm2 was overexpressed as compared to normal lung in 31% (60 out of 192) of all tumors analysed, whatever their histological types. Western blotting was performed on 28 out of the 192 tumoral samples. Overexpression of p85/90, p74/76 and p57 Mdm2 isoforms was detected in 18% (5 out of 28), 25% (7 out of 28) and 39% (11 out of 28) of the cases respectively. Overall, overexpression of at least one isoform was observed in 14 out of 28 (50%) lung tumors and concomittant overexpression of at least two isoforms in 7 out of 28 (25%) cases. A good concordance (82%) was observed between immunohistochemical and Western blot data. Interestingly, a highly significant inverse relationship was detected between p14ARF loss and Mdm2 overexpression either in NSCLC (P=0.0089) or in NE lung tumors (P<0.0001). Furthermore, a Mdm2/p14ARF >1 ratio was correlated with a high grade phenotype among NE tumors overexpressing Mdm2 (P=0.0021). Taken together, these data strongly suggest that p14ARFand Mdm2 act on common pathway(s) to regulate p53 and/or pRb-dependent or independent functions and that the Mdm2 : p14ARF ratio might act as a rheostat in modulating the activity of both proteins.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Abbreviations

ARF:

Alternative Reading Frame

IHC:

immunohistochemistry

LCNEC:

Large Cell NE Carcinoma

Mdm2:

Murine Double Minute 2

NE:

Neuroendocrine

NLS:

Nuclear Localization Signal

NrLS:

Nucleolar Localization Signal

NSCLC:

Non-Small Cell Lung Carcinoma

PBS:

Phosphate Buffer Saline

PMSF:

Phenylmethylsulphonate

pRb:

Retinoblastoma protein

SCLC:

Small Cell Lung carcinoma

SDS:

Sodium Dodecyl Sulfate

TPBS:

Tween Phosphate Buffer Saline

References

  • Aikawa H, Sato M, Fujimura S, Takahashi H, Endo C, Sakurada A, Chen Y, Kondo T, Tanita T, Matsumura Y, Saito Y, Sagawa M . 2000 Int. J. Mol. Med. 5: 631–633

  • Barak Y, Gottlieb E, Juven-Gershon T, Oren M . 1994 Genes Dev. 8: 1739–1749

  • Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH . 1998 Nature 395: 124–125

  • Brambilla E, Gazzeri S, Moro D, Caron de Fromentel C, Gouyer V, Jacrot M, Brambilla C . 1993 Am. J. Pathol. 143: 199–210

  • Brambilla E, Moro D, Gazzeri S, Brambilla C . 1999 J. Pathol. 188: 351–360

  • Bueso-Ramos CE, Manshouri T, Haidar MA, Yang Y, McCown P, Ordonez N, Glassman A, Sneige N, Albitar M . 1996 Breast Cancer Res. Treat. 37: 179–188

  • Buschmann T, Fuchs SY, Lee CG, Pan ZQ, Ronai Z . 2000 Cell 101: 753–762

  • Cahilly-Snyder L, Yang-Feng T, Francke U, George DL . 1987 Somat. Cell Mol. Genet. 13: 235–244

  • Carnero A, Hudson JD, Price CM, Beach DH . 2000 Nat. Cell Biol. 2: 148–155

  • Chen J, Marechal V, Levine AJ . 1993 Mol. Cell. Biol. 13: 4107–4114

  • Chiba I, Takahashi T, Nau MM, D'Amico D, Curiel DT, Mitsudomi T, Buchhagen DL, Carbone D, Piantadosi S, Koga H et al . 1990 Oncogene 5: 1603–1610

  • Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ . 1994 Cancer Res. 54: 794–799

  • Della Valle V, Duro D, Bernard O, Larsen CJ . 1997 Oncogene 15: 2475–2481

  • Esteller M, Cordon-Cardo C, Corn PG, Meltzer SJ, Pohar KS, Watkins DN, Capella G, Peinado MA, Matias-Guiu X, Prat J, Baylin SB, Herman JG . 2001 Cancer Res. 61: 2816–2821

  • Eymin B, Karayan L, Seite P, Brambilla C, Brambilla E, Larsen CJ, Gazzeri S . 2001 Oncogene 10: 1033–1041

  • Finlay CA . 1993 Mol. Cell. Biol. 13: 301–306

  • Foulkes WD, Stamp GW, Afzal S, Lalani N, McFarlane CP, Trowsdale J, Campbell IG . 1995 Br. J. Cancer 72: 883–888

  • Freedman DA, Levine AJ . 1998 Mol. Cell. Biol. 18: 7288–7293

  • Gazzeri S, Brambilla E, Caron de Fromentel C, Gouyer V, Moro D, Perron P, Berger F, Brambilla C . 1994 Int. J. Cancer 58: 24–32

  • Gazzeri S, Della Valle V, Chaussade L, Brambilla C, Larsen CJ, Brambilla E . 1998a Cancer Res. 58: 3926–3931

  • Gazzeri S, Gouyer V, Vour'ch C, Brambilla C, Brambilla E . 1998b Oncogene 16: 497–504

  • Geyer RK, Yu ZK, Maki CG . 2000 Nat. Cell Biol. 2: 569–573

  • Gorgoulis VG, Rassidakis GZ, Karameris AM, Papastamatiou H, Trigidou R, Veslemes M, Rassidakis AN, Kittas C . 1996a Mod. Pathol. 9: 544–554

  • Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C . 1998 Am. J. Pathol. 153: 1749–1765

  • Gorgoulis VG, Zacharatos P, Kotsinas A, Mariatos G, Liloglou T, Vogiatzi T, Foukas P, Rassidakis G, Garinis G, Ioannides T, Zoumpourlis V, Bramis J, Michail PO, Asimacopoulos PJ, Field JK, Kittas C . 2000 Mol. Med. 6: 208–237

  • Gorgoulis VG, Zoumpourlis V, Rassidakis GZ, Karameris A, Rassidakis AN, Spandidos DA, Kittas C . 1996b J. Pathol. 180: 129–137

  • Gouyer V, Gazzeri S, Bolon I, Drevet C, Brambilla C, Brambilla E . 1998 Am. J. Respir. Cell Mol. Biol. 17: 1–9

  • Gudas JM, Nguyen H, Klein RC, Katayose D, Seth P, Cowan KH . 1995 Clin. Cancer Res. 1: 71–80

  • Haidar MA, El-Hajj H, Bueso-Ramos CE, Manshouri T, Glassman A, Keating MJ, Maher A . 1997 Am. J. Hematol. 54: 189–195

  • Haines DS, Landers JE, Engle LJ, George DL . 1994 Mol. Cell. Biol. 14: 1171–1178

  • Haupt Y, Maya R, Kazaz A, Oren M . 1997 Nature 387: 296–299

  • Higashiyama M, Doi O, Kodama K, Yokouchi H, Kasugai T, Ishiguro S, Takami K, Nakayama T, Nishisho I . 1997 Br. J. Cancer 75: 1302–1308

  • Honda R, Yasuda H . 1999 EMBO J. 18: 22–27

  • Honda R, Yasuda H . 2000 Oncogene 19: 1473–1476

  • Horie S, Maeta H, Endo K, Ueta T, Takashima K, Terada T . 2001 Pathol. Int. 51: 11–15

  • Hsieh JK, Chan FS, O'Connor D, Mittnacht S, Zhong S, Lu X . 1999 Mol. Cell 3: 181–193

  • Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ . 1997 Cell 91: 649–659

  • Khosravi R, Maya R, Gottlieb T, Oren M, Shiloh Y, Shkedy D . 1999 Proc. Natl. Acad. Sci. USA 96: 14973–14977

  • Ko JL, Cheng YW, Chang SL, Su JM, Chen CY, Lee H . 2000 Int. J. Cancer 89: 265–270

  • Kubbutat MH, Jones SN, Vousden KH . 1997 Nature 387: 299–303

  • Lianes P, Orlow I, Zhang ZF, Oliva MR, Sarkis AS, Reuter VE, Cordon-Cardo C . 1994 J. Natl. Cancer Inst. 86: 1325–1330

  • Marchetti A, Buttitta F, Pellegrini S, Merlo G, Chella A, Angeletti CA, Bevilacqua G . 1995 Diagn. Mol. Pathol. 4: 93–97

  • Mariatos G, Gorgoulis VG, Kotsinas A, Zacharatos P, Kokotas S, Yannoukakos D, Kittas C . 2000 Mutat. Res. 456: 59–63

  • Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB, Kouzarides T . 1995 Nature 375: 691–694

  • Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O, Moas M, Buschmann T, Ronai Z, Shiloh Y, Kastan MB, Katzir E, Oren M . 2001 Genes Dev. 15: 1067–1077

  • McDonnell TJ, Montes de Oca Luna R, Cho S, Amelse LL, Chavez-Reyes A, Lozano G . 1999 J. Pathol. 188: 322–328

  • Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT, Lane DP . 2000 Oncogene 19: 2312–2323

  • Momand J, Zambetti GP, Olson DC, George D, Levine AJ . 1992 Cell 69: 1237–1245

  • O'Neill M, Campbell SJ, Save V, Thompson AM, Hall PA . 1998 J. Pathol. 186: 254–261

  • Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B . 1992 Nature 358: 80–83

  • Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B . 1993 Nature 362: 857–860

  • Olson DC, Marechal V, Momand J, Chen J, Romocki C, Levine AJ . 1993 Oncogene 8: 2353–2360

  • Perry ME, Mendrysa SM, Saucedo LJ, Tannous P, Holubar M . 2000 J. Biol. Chem. 275: 5733–5738

  • Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA . 1998 Cell 92: 713–723

  • Quelle DE, Ashmun RA, Hannon GJ, Rehberger PA, Trono D, Richter KH, Walker C, Beach D, Sherr CJ, Serrano M . 1995 Oncogene 11: 635–645

  • Ralhan R, Sandhya A, Meera M, Bohdan W, Nootan SK . 2000 Am. J. Pathol. 157: 587–596

  • Rasidakis A, Orphanidou D, Kalomenidis J, Papamichalis G, Toumbis M, Lambaditis J, Sacharidou A, Papastamatiou H, Jordanoglou J . 1998 Hybridoma 17: 339–345

  • Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M, McCormick F . 2000a Cell 103: 321–330

  • Ries SJ, Brandts CH, Chung AS, Biederer CH, Hann BC, Lipner EM, McCormick F, Korn WM . 2000b Nat. Med. 6: 1128–1133

  • Rodenhuis S, Slebos RJ . 1992 Cancer Res. 52: 2665S–2669S

  • Roth J, Dobbelstein M, Freedman DA, Shenk T, Levine AJ . 1998 EMBO J. 17: 554–564

  • Stefanaki K, Rontogiannis D, Vamvouka C, Bolioti S, Chaniotis V, Sotsiou F, Vlychou M, Delidis G, Kakolyris S, Georgoulias V, Kanavaros P . 1998 Anticancer Res. 18: 1689–1695

  • Sun P, Dong P, Dai K, Hannon GJ, Beach D . 1998 Science 282: 2270–2272

  • Tao W, Levine AJ . 1999a Proc. Natl. Acad. Sci. USA 96: 3077–3080

  • Tao W, Levine AJ . 1999b Proc. Natl. Acad. Sci. USA 96: 6937–6941

  • Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E . 1999 Histological typing of lung and pleural tumors World Health Organization: International histological classification of tumours. 3rd edn Berlin, Heidelberg, New York: Springer 157 pp

    Google Scholar 

  • Weber JD, Jeffers JR, Rehg JE, Randle D, Lozano G, Roussel MF, Sherr CJ, Zambetti GP . 2000 Genes Dev. 14: 2358–2365

  • Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D . 1999 Nat. Cell Biol. 1: 20–26

  • Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR, Livingston DM . 1995 Nature 375: 694–698

  • Xu HJ, Cagle PT, Hu SX, Li J, Benedict WF . 1996 Clin. Cancer Res. 2: 1169–1176

  • Yap DB, Hsieh JK, Chan FS, Lu X . 1999 Oncogene 18: 7681–7689

  • Zhang Y, Xiong Y . 1999 Mol. Cell 3: 579–591

  • Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF . 1998 Genes Dev. 12: 2424–2433

Download references

Acknowledgements

We thank Christiane Oddou, Pascal Perron, Christine Claraz and Sylvie Veyrenc for technical assistance. This work was supported by grants from the Association pour la Recherche sur le Cancer, from the Comité Départmental de la Ligue contre le Cancer de l'Isère and from the Comité National de la Ligue contre le Cancer. B Eymin was supported by INSERM (Poste Accueil).

Author information

Author notes

  1. Béatrice Eymin and Sylvie Gazzeri: B Eymin and S Gazzeri contributed equally to this work

Authors and Affiliations

  1. Groupe de Recherche sur le Cancer du Poumon, EA 2021, Equipe INSERM 9924, Institut Albert Bonniot, La Tronche, 38706, Cedex, France

    Béatrice Eymin, Sylvie Gazzeri, Christian Brambilla & Elisabeth Brambilla

Authors
  1. Béatrice Eymin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sylvie Gazzeri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christian Brambilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elisabeth Brambilla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sylvie Gazzeri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eymin, B., Gazzeri, S., Brambilla, C. et al. Mdm2 overexpression and p14ARF inactivation are two mutually exclusive events in primary human lung tumors. Oncogene 21, 2750–2761 (2002). https://doi.org/10.1038/sj.onc.1205359

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205359

Keywords

This article is cited by

Search

Advanced search

Quick links